Skip to main content
. 2021 Aug 10;16(8):e0255831. doi: 10.1371/journal.pone.0255831

Table 1. Peak list and diagnostics of selected metabolites from pomegranate matrices object of this study.

Peak no. Rt, mina compound tentative identification UV-vis data, nmb MW ESI- data, m/zc
1 2.8 lagerstannin C (galloyl-HHDP-glucose) 238, 260sh 650 649 (M-H)-, 301*
2 3.8 HHDP-hexoside 258, 280 sh 482 481 (M-H)-, 345*
3 5.2 galloyl hexoside 279.4 332 331 (M-H)-
4 5.5 galloyl-HHDP- hexoside 278 634 633 (M-H)-, 301*
5 6.0 gallic acidd 280 170 169 (M-H)-
6 6,3 punicalagin derivative 269, 370 1124 1123(M-H)-, 1101
7 6.6 punicalin (gallagyl-hexoside) 259, 380 782 781(M-H)-, 601*
8 6.9 punicalin isomer 259, 381 782 781(M-H)-
9 7.4 di(HHDP-galloylglucose)-pentoside 243.4, 268.2 1416 1415(M-H)-, 783*
10 7.7 punicalagin isomer 243.8, 370 1084 1083 (M-H)-
11 7.8 pedunculagin isomer 1 243.3 784 783(M-H)-, 601*
12 8.2 galloyl hexoside isomer 280 332 331, 169*
13 8.7 digalloyl-hexoside 240, 272 484 483(M-H)-, 271*
14 9.4 punicalagin ad 357.9, 378.2 1084 1083 (M-H)-, 601*
15 9.9 punicalagin isomer 257, 378 1084 1083 (M-H)-
16 10.5 pedunculagin III 243.7 934 933(M-H)-, 721*
17 10.9 pedunculagin isomer 2 244.6, 264.6 784 783(M-H)-, 301*
18 11.3 punicalagin bd 257.9, 379 1084 1083 (M-H)-*, 601
19 12.2 punigluconin isomer 244.9 802 801(M-H)-, 347*
20 12.9 ellagic acid deoxy-hexoside 254, 362 448 447(M-H)-, 301*
21 13.6 Punigluconin 272.8 802 801(M-H)-, 649*
22 14.3 pedunculagin isomer 3 270 784 783(M-H)-, 301*
23 14.8 pedunculagin II 269.7 786 785 (M-H)-, 633*
24 15.0 pedunculagin isomer 4 271.6 784 783(M-H)-, 765*
25 15.3 pedunculagin isomer 5 271 784 783(M-H)-, 765*
26 15.8 ellagic acid hexoside 252, 360 464 463 (M-H)-, 301*
27 16.4 granatin B 278 952 951(M-H)-, 933*
28 16.9 granatin B isomer 278 952 951(M-H)-
29 17.8 ellagic acid galloyl-hexoside 253, 360 616 615(M-H)-, 301*
30 18.6 ellagic acid pentoside 253, 358 434 433 (M-H)-*
31 18.8 ellagic acid galloyl-hexoside isomer 253, 360 616 615(M-H)-*
32 19.2 ellagic acidd 252, 365 302 301(M-H)-*

a as mean of six matrices x three replicates = 18 analyses;

b from HPLC;

c base peaks marked with an asterisk;

d co-injection with pure commercial standard (refer to Fig 2 and text for details).